CCL5 and CXCL9-11 expression in melanoma correlated with increased CD8+ T cell infiltration (6), improved survival (24) and response to adoptive T cell therapy (38) CCL5, CXCL9-10 were associated with response to MAGE-A3 vaccine (39) CXCL9-11 recruited γδ T cells into melanoma (40). The gene discussed is CD8A; the disease is melanoma.